Pulmonology
Latest News
LAMA-LABA surpasses corticosteroid combination as COPD therapy
Large matched cohort study suggests stronger safety and effectiveness outcomes with LAMA-LABA inhalers vs. ICS-LABA inhalers.
From the Journals
Spirometry predicts mortality in type 2 diabetes
PRISm occurs in approximately 10% of the general population and has been identified as a predictor of adverse health outcomes.
Feature
Parsing the split-decision victory for biologics in COPD
It’s tough to keep up with the proliferation of monoclonal antibodies.
Feature
Geriatric care principles should apply to ICUs as well
Physical frailty, disabilities, and multimorbidities increase the risk for adverse outcomes among elderly patients with obstructive airways...
From the Journals
Pulmonary embolism confers higher mortality long term
The most frequent causes of death were cancer, pulmonary embolism, infections, and cardiovascular events.
From the Journals
Comorbid respiratory disease key predictor of NTM-PD
Overall, comorbid respiratory disease was significantly associated with an increased risk of NTM-PD.
News from the FDA/CDC
CDC signs off on RSV vaccine for older adults
The vote recommending shared decision making about the vaccine, instead of a routine vaccination recommended for all, “is a weaker recommendation...
From the Journals
Observation recommended as first-line therapy in select cases of primary spontaneous pneumothorax
Observation was the dominant choice, based on economic modeling showing it to offer both the highest utility and the lowest cost.
Latest News
Few of those eligible get lung cancer screening, despite USPSTF recommendations
Fewer than 13% who are eligible get CT screening. Results highlight the need for education, Medicare coverage, and recognition of stigma’s role,...
From the Journals
Rehabilitation improves walk test results for post–pulmonary embolism patients with persistent dyspnea
In patients with persistent dyspnea following a pulmonary embolism, rehabilitation should be considered as a treatment option.